United Net Debt vs Net Tangible Assets Analysis

UTHR Stock  USD 363.65  4.07  1.13%   
United Therapeutics financial indicator trend analysis is much more than just breaking down United Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether United Therapeutics is a good investment. Please check the relationship between United Therapeutics Net Debt and its Net Tangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.

Net Debt vs Net Tangible Assets

Net Debt vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of United Therapeutics Net Debt account and Net Tangible Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between United Therapeutics' Net Debt and Net Tangible Assets is -0.15. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of United Therapeutics, assuming nothing else is changed. The correlation between historical values of United Therapeutics' Net Debt and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of United Therapeutics are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Net Debt i.e., United Therapeutics' Net Debt and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

-0.15
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from United Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into United Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.At this time, United Therapeutics' Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 12/23/2024, Enterprise Value Multiple is likely to grow to 10.85, while Discontinued Operations is likely to drop 5,600.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.8B2.1B2.2B
Total Revenue1.7B1.9B2.3B2.4B

United Therapeutics fundamental ratios Correlations

0.840.710.641.00.97-0.140.97-0.220.850.990.330.920.740.240.560.89-0.30.890.990.920.460.950.990.830.48
0.840.50.370.80.80.260.8-0.250.610.860.20.90.430.130.820.77-0.30.920.80.840.40.820.790.820.51
0.710.50.290.720.67-0.350.76-0.050.710.680.50.650.780.160.40.63-0.450.540.710.60.410.590.680.740.27
0.640.370.290.630.69-0.310.57-0.190.610.630.230.360.690.45-0.090.560.020.580.620.480.420.530.650.470.24
1.00.80.720.630.96-0.190.98-0.220.860.980.330.90.740.20.510.88-0.310.850.990.910.420.950.990.810.47
0.970.80.670.690.96-0.180.94-0.150.850.960.430.860.790.40.530.84-0.310.90.960.920.610.880.960.820.55
-0.140.26-0.35-0.31-0.19-0.18-0.260.12-0.59-0.04-0.57-0.01-0.58-0.10.39-0.160.410.12-0.23-0.01-0.270.06-0.170.130.03
0.970.80.760.570.980.94-0.26-0.280.910.940.490.920.780.110.540.91-0.50.830.980.920.450.890.940.750.54
-0.22-0.25-0.05-0.19-0.22-0.150.12-0.28-0.3-0.19-0.14-0.3-0.210.41-0.11-0.330.34-0.2-0.26-0.130.06-0.2-0.20.020.05
0.850.610.710.610.860.85-0.590.91-0.30.790.630.770.860.20.350.8-0.560.690.890.740.540.680.830.570.41
0.990.860.680.630.980.96-0.040.94-0.190.790.270.90.690.260.580.84-0.250.910.950.920.440.930.970.860.49
0.330.20.50.230.330.43-0.570.49-0.140.630.270.370.660.070.210.42-0.860.310.380.440.650.120.260.140.57
0.920.90.650.360.90.86-0.010.92-0.30.770.90.370.610.110.790.88-0.440.90.910.890.450.890.880.760.44
0.740.430.780.690.740.79-0.580.78-0.210.860.690.660.610.390.210.73-0.480.630.770.590.640.540.740.560.26
0.240.130.160.450.20.4-0.10.110.410.20.260.070.110.390.120.080.360.390.220.130.70.160.310.4-0.07
0.560.820.4-0.090.510.530.390.54-0.110.350.580.210.790.210.120.53-0.320.750.530.620.430.580.50.60.35
0.890.770.630.560.880.84-0.160.91-0.330.80.840.420.880.730.080.53-0.460.810.920.80.40.860.860.650.39
-0.3-0.3-0.450.02-0.31-0.310.41-0.50.34-0.56-0.25-0.86-0.44-0.480.36-0.32-0.46-0.25-0.35-0.44-0.29-0.14-0.21-0.07-0.54
0.890.920.540.580.850.90.120.83-0.20.690.910.310.90.630.390.750.81-0.250.850.840.590.830.860.820.46
0.990.80.710.620.990.96-0.230.98-0.260.890.950.380.910.770.220.530.92-0.350.850.890.460.940.970.780.45
0.920.840.60.480.910.92-0.010.92-0.130.740.920.440.890.590.130.620.8-0.440.840.890.460.880.880.760.73
0.460.40.410.420.420.61-0.270.450.060.540.440.650.450.640.70.430.4-0.290.590.460.460.30.460.460.32
0.950.820.590.530.950.880.060.89-0.20.680.930.120.890.540.160.580.86-0.140.830.940.880.30.940.810.42
0.990.790.680.650.990.96-0.170.94-0.20.830.970.260.880.740.310.50.86-0.210.860.970.880.460.940.820.37
0.830.820.740.470.810.820.130.750.020.570.860.140.760.560.40.60.65-0.070.820.780.760.460.810.820.35
0.480.510.270.240.470.550.030.540.050.410.490.570.440.26-0.070.350.39-0.540.460.450.730.320.420.370.35
Click cells to compare fundamentals

United Therapeutics Account Relationship Matchups

United Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.9B4.6B5.2B6.0B7.2B7.5B
Other Current Liab39.6M319.2M301.6M339.1M398.8M418.7M
Total Current Liabilities463M323.3M305.4M343.2M804.4M844.6M
Total Stockholder Equity2.8B3.4B4.0B4.8B6.0B6.3B
Property Plant And Equipment Net738.5M731.6M780.9M861.5M1.0B1.1B
Net Debt111.6M61.3M(94.8M)(161.2M)(507.7M)(482.3M)
Retained Earnings3.3B3.8B4.3B5.0B6.0B6.3B
Accounts Payable23.1M9.9M4.1M3.8M5.6M10.2M
Cash738.4M738.7M894.8M961.2M1.2B1.3B
Non Current Assets Total2.0B2.4B2.8B2.7B3.6B3.8B
Non Currrent Assets Other154.6M169.9M108.2M114.3M151.8M91.5M
Cash And Short Term Investments2.3B3.0B3.6B4.2B3.0B3.1B
Net Receivables151.4M157.4M198.7M220.4M278.9M292.8M
Common Stock Shares Outstanding43.8M44.6M47.3M48.5M49.7M50.7M
Liabilities And Stockholders Equity3.9B4.6B5.2B6.0B7.2B7.5B
Non Current Liabilities Total670M896.5M904.8M904.6M377.8M269.4M
Other Current Assets133.8M88.3M100.4M219.2M166.2M174.5M
Other Stockholder Equity(531.3M)(430.5M)(333.8M)(190.8M)(30.2M)(28.7M)
Total Liab1.1B1.2B1.2B1.2B1.2B1.2B
Total Current Assets1.9B2.2B2.3B3.4B3.6B3.7B
Short Term Investments747.5M1.1B1.0B1.9B1.8B1.9B
Property Plant And Equipment Gross738.5M731M1.1B1.2B1.5B1.5B
Intangible Assets130.3M130.1M16.6M16.5M80.5M84.5M
Other Liab67M79.4M104.8M76.8M88.3M60.5M
Other Assets293.8M1.6B370.1M413.5M475.5M284.7M
Inventory93.4M86.5M93.8M102M111.8M55.9M
Property Plant Equipment738.5M731.6M780.9M861.5M990.7M1.0B
Net Tangible Assets2.6B3.2B3.9B4.8B5.5B5.7B
Retained Earnings Total Equity3.3B3.8B4.3B5.0B5.8B6.1B

Pair Trading with United Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if United Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against United Stock

  0.38VINC Vincerx PharmaPairCorr
  0.32ME 23Andme HoldingPairCorr
  0.32DOMH Dominari HoldingsPairCorr
The ability to find closely correlated positions to United Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace United Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back United Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling United Therapeutics to buy it.
The correlation of United Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as United Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if United Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for United Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for United Stock Analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.